Sign In

Login

Password

Forgot Password ? Sign Up

BCG vakcína (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "BCG vakcína" in Czech language version.

refsWebsite
Global rank Czech rank
53nih.gov
4th place
8th place
47doi.org
2nd place
4th place
25web.archive.org
1st place
1st place
17semanticscholar.org
11th place
313th place
5harvard.edu
18th place
99th place
4worldcat.org
5th place
3rd place
4hathitrust.org
441st place
1,181st place
4who.int
195th place
168th place
2cdc.gov
218th place
304th place
2bcgatlas.org
low place
low place
2books.google.com
3rd place
25th place
1theconversation.com
928th place
1,272nd place
1ucl.ac.uk
1,306th place
3,266th place
1bestbets.org
low place
low place
1cancer.org
3,680th place
2,061st place
1usm.my
low place
low place
1tandfonline.com
507th place
215th place
1elsevier.com
610th place
203rd place
1toronto.ca
4,401st place
low place
1sciensano.be
low place
low place
1szu.cz
low place
873rd place
1thl.fi
low place
low place
1hcsp.fr
low place
low place
1moh.gov.gr
low place
low place
1antsz.hu
low place
low place
1irishtimes.com
266th place
824th place
1fhi.no
low place
low place
1csid.ro
low place
low place
1vacunas.org
low place
low place
1folkhalsomyndigheten.se
low place
low place
1ligazakon.ua
low place
low place
1bbc.co.uk
8th place
28th place
1nhs.uk
1,989th place
1,996th place
1fhs.gov.hk
low place
low place
1mhlw.go.jp
1,656th place
low place
1pidst.net
low place
low place
1dawn.com
354th place
3,962nd place
1jamanetwork.com
2,650th place
1,128th place
1academie-medecine.fr
8,215th place
low place
1rch.org.au
low place
low place
1biomedlublin.com
low place
low place
1rxmed.com
low place
low place
1ssi.dk
low place
low place
1unicef.org
1,791st place
1,398th place
1fda.gov
447th place
753rd place
1hemonc.org
low place
low place
1fiercepharma.com
low place
low place
1fiercepharmamanufacturing.com
low place
low place
1archive.org
6th place
10th place
1aptnnews.ca
low place
low place
1gezondheidsraad.nl
low place
low place
1nature.com
234th place
72nd place
1clinicaltrials.gov
5,225th place
2,661st place

academie-medecine.fr

  • Évolution du calendrier vaccinal au Maroc [online]. 29 May 2006. Dostupné online. 

antsz.hu

  • A tuberkulózis és a tuberkulózis elleni védőoltás (BCG) [online]. 17 July 2015. Dostupné online. 

aptnnews.ca

  • BLACKBURN, Mark. First Nation infants subject to "human experimental work" for TB vaccine in 1930s-40s [online]. 24 July 2013 [cit. 2021-03-31]. Dostupné online. (anglicky) 

archive.org

  • VILLEMIN, J.-A. De la virulence et de la spécificité de la tuberculose. Paris, France: Victor Masson et fils, 1868a. Dostupné online. (francouzsky) 

bbc.co.uk

news.bbc.co.uk

  • School 'TB jabs' to be scrapped. BBC News Online. 6 July 2005. Dostupné v archivu pořízeném z originálu dne 6 March 2012. 

bcgatlas.org

  • Database of Global BCG Vaccination Policies and Practices [online]. The BCG World Atlas [cit. 2020-10-21]. Dostupné online. 
  • BCG WORLD ATLAS. A Database of Global BCG Vaccination Policies and Practices [online]. [cit. 2020-04-04]. Dostupné v archivu pořízeném z originálu dne 12 June 2009. 

bestbets.org

  • Nick Makwana and Andrew Riordan (2004), "Is medical therapy effective in the treatment of BCG abscesses?", Birmingham Heartlands Hospital BestBets: Is medical therapy effective in the treatment of BCG abscesses? [online]. [cit. 2007-04-01]. Dostupné v archivu pořízeném z originálu dne 16 February 2007. 

biomedlublin.com

  • Onko BCG 100 Biomed Lublin [online]. biomedlublin.com [cit. 2021-03-03]. Dostupné online. 

books.google.com

  • Villemin JA. Études sur la Tuberculose. Paris, France: J.-B. Baillière et fils, 1868. Dostupné online. S. 528–597. (francouzsky)  (§ "Seizième Étude: La tuberculose est inoculable" (Sixteenth study: Tuberculosis can be transmitted by inoculation))
  • SMITH, Theobald. Investigations of diseases of domesticated animals. Annual Report of the Bureau of Animal Industry (U.S. Department of Agriculture). 1895, s. 119–185. Dostupné online.  See § "Two varieties of the tubercle bacillus from mammals." pp. 149-161.
    • SMITH, Theobald. Two varieties of the tubercle bacillus from mammals. Transactions of the Association of American Physicians. 1896, s. 75–95. Dostupné online. 

cancer.org

cdc.gov

  • Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR. Recommendations and Reports. April 1996, s. 1–18. Dostupné online. PMID 8602127. 
  • Fact Sheets: BCG Vaccine [online]. Centers for Disease Control and Prevention, 28 October 2011 [cit. 2013-07-18]. Dostupné v archivu pořízeném z originálu dne 20 July 2013. 

clinicaltrials.gov

  • Studies found for BCG Recruiting, Active, not recruiting Studies Covid19 [online]. Dostupné online. 

csid.ro

  • Vaccinări cu obligativitate generală [online]. [cit. 2020-04-14]. Dostupné online. 

dawn.com

  • CHAUDHRY, Asif. Millions of infants denied anti-TB vaccination. Dawn. Pakistan: 24 February 2015. Dostupné online [cit. 8 April 2020]. 

doi.org

  • HAWGOOD, Barbara J. Albert Calmette (1863-1933) and Camille Guérin (1872-1961): the C and G of BCG vaccine. Journal of Medical Biography. August 2007, s. 139–146. Dostupné online. ISSN 0967-7720. doi:10.1258/j.jmb.2007.06-15. PMID 17641786. S2CID 41880560. 
  • Fuge O, Vasdev N, Allchorne P, Green JS. Immunotherapy for bladder cancer. Research and Reports in Urology. May 2015, s. 65–79. doi:10.2147/RRU.S63447. PMID 26000263. 
  • Houghton BB, Chalasani V, Hayne D, Grimison P, Brown CS, Patel MI, Davis ID, Stockler MR. Intravesical chemotherapy plus bacille Calmette–Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis. BJU International. May 2013, s. 977–83. doi:10.1111/j.1464-410X.2012.11390.x. PMID 23253618. S2CID 24961108. 
  • Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, Snell L, Mangtani P, Adetifa I, Lalvani A, Abubakar I. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. August 2014, s. g4643. doi:10.1136/bmj.g4643. PMID 25097193. 
  • Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. March 1994, s. 698–702. doi:10.1001/jama.1994.03510330076038. PMID 8309034. 
  • Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. November 1995, s. 1339–45. doi:10.1016/S0140-6736(95)92348-9. PMID 7475776. S2CID 44737409. 
  • Venkataswamy MM, Goldberg MF, Baena A, Chan J, Jacobs WR, Porcelli SA. In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG. Vaccine. February 2012, s. 1038–49. doi:10.1016/j.vaccine.2011.12.044. PMID 22189700. 
  • Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA. May 2004, s. 2086–91. doi:10.1001/jama.291.17.2086. PMID 15126436. 
  • Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. International Journal of Epidemiology. December 1993, s. 1154–8. doi:10.1093/ije/22.6.1154. PMID 8144299. 
  • Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, Valenti P, Dos Santos S, Duthoy S, Lacroix C, Garcia-Pelayo C, Inwald JK, Golby P, Garcia JN, Hewinson RG, Behr MA, Quail MA, Churcher C, Barrell BG, Parkhill J, Cole ST. Genome plasticity of BCG and impact on vaccine efficacy. Proceedings of the National Academy of Sciences of the United States of America. March 2007, s. 5596–601. doi:10.1073/pnas.0700869104. PMID 17372194. Bibcode 2007PNAS..104.5596B. 
  • Packe GE, Innes JA. Protective effect of BCG vaccination in infant Asians: a case-control study. Archives of Disease in Childhood. March 1988, s. 277–81. doi:10.1136/adc.63.3.277. PMID 3258499. 
  • Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. April 2002, s. 1393–401. doi:10.1016/S0140-6736(02)08353-8. PMID 11978337. S2CID 24334622. 
  • Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. The American Review of Respiratory Disease. October 1966, s. 553–68. doi:10.1164/arrd.1966.94.4.553. PMID 5924215. 
  • Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infection and Immunity. February 2002, s. 672–8. doi:10.1128/IAI.70.2.672-678.2002. PMID 11796598. 
  • Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?. Vaccine. March 2005, s. 2115–20. Dostupné v archivu pořízeném z originálu dne 22 September 2017. doi:10.1016/j.vaccine.2005.01.069. PMID 15755581. 
  • Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infection and Immunity. September 2001, s. 5403–11. doi:10.1128/IAI.69.9.5403-5411.2001. PMID 11500410. 
  • Rentsch CA, Birkhäuser FD, Biot C, Gsponer JR, Bisiaux A, Wetterauer C, Lagranderie M, Marchal G, Orgeur M, Bouchier C, Bachmann A, Ingersoll MA, Brosch R, Albert ML, Thalmann GN. Bacillus Calmette–Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy. European Urology. October 2014, s. 677–88. doi:10.1016/j.eururo.2014.02.061. PMID 24674149. 
  • Brandau S, Suttmann H. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomedicine & Pharmacotherapy. July 2007, s. 299–305. doi:10.1016/j.biopha.2007.05.004. PMID 17604943. 
  • Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA, Sullivan J, Sarosdy MF. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette–Guérin for transitional-cell carcinoma of the bladder. The New England Journal of Medicine. October 1991, s. 1205–9. doi:10.1056/NEJM199110243251703. PMID 1922207. 
  • Mosolits S, Nilsson B, Mellstedt H. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Review of Vaccines. June 2005, s. 329–50. doi:10.1586/14760584.4.3.329. PMID 16026248. S2CID 35749038. 
  • Cuello-García CA, Pérez-Gaxiola G, Jiménez Gutiérrez C. Treating BCG-induced disease in children. The Cochrane Database of Systematic Reviews. January 2013, s. CD008300. doi:10.1002/14651858.CD008300.pub2. PMID 23440826. 
  • NUMMI, Antti; JÄRVINEN, Riikka; SAIRANEN, Jukka; HUOTARI, Kaisa. A retrospective study on tolerability and complications of bacillus Calmette–Guérin (BCG) instillations for non-muscle-invasive bladder cancer. Scandinavian Journal of Urology. 4 May 2019, s. 116–122. Dostupné online. ISSN 2168-1805. doi:10.1080/21681805.2019.1609080. PMID 31074322. S2CID 149444603. (anglicky) 
  • LIU, Yuqing; LU, Jian; HUANG, Yi; MA, Lulin. Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette–Guérin for Bladder Cancer. Journal of Oncology. 10 March 2019, s. 1–11. ISSN 1687-8450. doi:10.1155/2019/6230409. PMID 30984262. (anglicky) 
  • CABAS, Paolo; RIZZO, Michele; GIUFFRÈ, Mauro; ANTONELLO, Roberta Maria; TROMBETTA, Carlo; LUZZATI, Roberto; LIGUORI, Giovanni. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review. Urologic Oncology: Seminars and Original Investigations. February 2021, s. 85–92. Dostupné online. doi:10.1016/j.urolonc.2020.11.037. PMID 33308969. S2CID 229179250. (anglicky) 
  • Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. April 2006, s. 1173–80. doi:10.1016/S0140-6736(06)68507-3. PMID 16616560. S2CID 40371125. 
  • Mak TK, Hesseling AC, Hussey GD, Cotton MF. Making BCG vaccination programmes safer in the HIV era. Lancet. September 2008, s. 786–7. doi:10.1016/S0140-6736(08)61318-5. PMID 18774406. S2CID 6702107. 
  • Rousseau MC, Conus F, Kâ K, El-Zein M, Parent MÉ, Menzies D. Bacillus Calmette–Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974. Vaccine. August 2017, s. 4777–4784. doi:10.1016/j.vaccine.2017.06.064. PMID 28705514. 
  • Rieckmann A, Villumsen M, Sørup S, Haugaard LK, Ravn H, Roth A, Baker JL, Benn CS, Aaby P. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971-2010. International Journal of Epidemiology. April 2017, s. 695–705. doi:10.1093/ije/dyw120. PMID 27380797. S2CID 3792173. 
  • Gabriele F, Katragkou A, Roilides E. BCG vaccination policy in Greece: time for another review?. The International Journal of Tuberculosis and Lung Disease. October 2014, s. 1258. doi:10.5588/ijtld.14.0282. PMID 25216844. 
  • ZWERLING, A.; BEHR, M. A.; VERMA, A.; BREWER, T. F.; MENZIES, D.; PAI, M. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLOS Medicine. 2011, s. e1001012. doi:10.1371/journal.pmed.1001012. PMID 21445325. 
  • Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle. March 1976, s. 17–43. doi:10.1016/0041-3879(76)90015-5. PMID 1085050. 
  • SADEGHI-SHANBESTARI, Mahnaz; ANSARIN, Khalil; MALJAEI, Seyed Hudieh; RAFEEY, Mandana; PEZESHKI, Zakaria; KOUSHA, Ahmmad; BARADARAN, Reza. Immunologic aspects of patients with disseminated bacille Calmette–Guerin disease in north-west of Iran. Italian Journal of Pediatrics. 2009, s. 42. doi:10.1186/1824-7288-35-42. PMID 20030825. 
  • Cernuschi T, Malvolti S, Nickels E, Friede M. Bacillus Calmette–Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine. January 2018, s. 498–506. doi:10.1016/j.vaccine.2017.12.010. PMID 29254839. 
  • Ungar J, Muggleton PW, Dudley JA, Griffiths MI. Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability. Br Med J. October 1962, s. 1086–9. doi:10.1136/bmj.2.5312.1086. PMID 13995378. 
  • PALMER, Mitchell V.; WATERS, W. Ray. Bovine tuberculosis and the establishment of an eradication program in the United States: Role of veterinarians. Veterinary Medicine International. May 2011, s. 816345. doi:10.4061/2011/816345. PMID 21647341. S2CID 18020962.  From p. 2: "In 1895, Smith visited Koch in Europe and described his findings."
  • KOCH, Robert. An address on the combatting of tuberculosis in the light of experience that has been gained in the successful combatting of other infectious diseases.. The Lancet. 27 July 1901, s. 187–191. Dostupné online. doi:10.1016/S0140-6736(01)85122-9.  From p. 189: "Considering all these facts, I feel justified in maintaining that human tuberculosis differs from bovine and cannot be transmitted to cattle."
  • Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, Stensballe L, Diness BR, Lausch KR, Lund N, Biering-Sørensen S, Whittle H, Benn CS. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. The Journal of Infectious Diseases. July 2011, s. 245–52. doi:10.1093/infdis/jir240. PMID 21673035. 
  • Biering-Sørensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, Benn CS. Small randomized trial among low-birth-weight children receiving bacillus Calmette–Guérin vaccination at first health center contact. The Pediatric Infectious Disease Journal. March 2012, s. 306–8. doi:10.1097/inf.0b013e3182458289. PMID 22189537. S2CID 1240058. 
  • Darrah PA, Zeppa JJ, Maiello P, Hackney JA, Wadsworth MH, Hughes TK, Pokkali S, Swanson PA, Grant NL, Rodgers MA, Kamath M, Causgrove CM, Laddy DJ, Bonavia A, Casimiro D, Lin PL, Klein E, White AG, Scanga CA, Shalek AK, Roederer M, Flynn JL, Seder RA. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. January 2020, s. 95–102. doi:10.1038/s41586-019-1817-8. PMID 31894150. Bibcode 2020Natur.577...95D. 
  • Behar SM, Sassetti C. Tuberculosis vaccine finds an improved route. Nature. January 2020, s. 31–32. doi:10.1038/d41586-019-03597-y. PMID 31894152. S2CID 209528484. Bibcode 2020Natur.577...31B. 
  • The trick that could inject new life into an old tuberculosis vaccine. Nature. January 2020, s. 145. Dostupné online. doi:10.1038/d41586-020-00003-w. PMID 31911698. S2CID 210044794. Bibcode 2020Natur.577..145.. 
  • Kühtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, Zheng H, Faustman DL. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. NPJ Vaccines. 2018, s. 23. doi:10.1038/s41541-018-0062-8. PMID 29951281. 
  • Kowalewicz-Kulbat M, Locht C. BCG and protection against inflammatory and auto-immune diseases. Expert Review of Vaccines. July 2017, s. 699–708. doi:10.1080/14760584.2017.1333906. PMID 28532186. S2CID 4723444. 
  • Weng CH, Saal A, Butt WW, Bica N, Fisher JQ, Tao J, Chan PA. Bacillus Calmette–Guérin vaccination and clinical characteristics and outcomes of covid-19 in Rhode Island, United States: a cohort study. Epidemiology and Infection. July 2020, s. e140. doi:10.1017/S0950268820001569. PMID 32641191. 
  • Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (covid-19). Proceedings of the National Academy of Sciences of the United States of America. July 2020, s. 17720–17726. doi:10.1073/pnas.2008410117. PMID 32647056. S2CID 220469598. 
  • KLINGER, Danielle; BLASS, Ido; RAPPOPORT, Nadav; LINIAL, Michal. Significantly Improved covid-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis. Vaccines. 11 July 2020, s. 378. doi:10.3390/vaccines8030378. PMID 32664505. S2CID 220528079. 
  • SZIGETI, Reka; KELLERMAYER, Domos; TRAKIMAS, Giedrius; KELLERMAYER, Richard. BCG epidemiology supports its protection against covid-19? A word of caution. PLOS ONE. 7 October 2020, s. e0240203. doi:10.1371/journal.pone.0240203. PMID 33027297. Bibcode 2020PLoSO..1540203S. 

elsevier.com

linkinghub.elsevier.com

  • CABAS, Paolo; RIZZO, Michele; GIUFFRÈ, Mauro; ANTONELLO, Roberta Maria; TROMBETTA, Carlo; LUZZATI, Roberto; LIGUORI, Giovanni. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review. Urologic Oncology: Seminars and Original Investigations. February 2021, s. 85–92. Dostupné online. doi:10.1016/j.urolonc.2020.11.037. PMID 33308969. S2CID 229179250. (anglicky) 

fda.gov

  • April 2012 Inspectional Observations (form 483). U.S. Food and Drug Administration. 12 April 2012. Dostupné v archivu pořízeném z originálu dne 6 February 2016. 

fhi.no

fhs.gov.hk

  • Child health – Immunisation [online]. [cit. 2020-01-06]. Dostupné online. 

fiercepharma.com

  • PALMER, Eric. UPDATED: Merck again shipping BCG cancer treatment but Sanofi still is not. FiercePharma. 10 September 2014. Dostupné online. 

fiercepharmamanufacturing.com

  • PALMER, Eric. Sanofi Canada vax plant again producing ImmuCyst bladder cancer drug. FiercePharma. 31 March 2015. Dostupné v archivu pořízeném z originálu dne 5 February 2016. 

folkhalsomyndigheten.se

  • Tuberkulos (TB) – om vaccination – Folkhälsomyndigheten [online]. Dostupné online. 

gezondheidsraad.nl

  • Vaccination of young children against tuberculosis. [s.l.]: The Hague:Health Council of the Netherlands, 2011. Dostupné v archivu pořízeném z originálu dne 19 February 2014. ISBN 978-90-5549-844-4. 

harvard.edu

adsabs.harvard.edu

hathitrust.org

babel.hathitrust.org

  • Villemin JA. Cause et nature de la tuberculose. Bulletin de l'Académie Impériale de Médecine. 1865, s. 211–216. Dostupné online. (francouzsky) 
  • KOCH, Robert. Die Aetologie der Tuberculose. Berliner Klinische Wochenschrift. 10 April 1882, s. 221–230. Dostupné online. (německy)  From p. 230: "Die Perlsucht ist identisch mit der Tuberculose des Menschen und also eine auf diesen übertragbare Krankheit." (Pearl disease [i.e., bovine tuberculosis] is identical with the tuberculosis of humans and thus [is] a disease that can be transmitted to them.)
  • SMITH, Theobald. Investigations of diseases of domesticated animals. Annual Report of the Bureau of Animal Industry (U.S. Department of Agriculture). 1895, s. 119–185. Dostupné online.  See § "Two varieties of the tubercle bacillus from mammals." pp. 149-161.
    • SMITH, Theobald. Two varieties of the tubercle bacillus from mammals. Transactions of the Association of American Physicians. 1896, s. 75–95. Dostupné online. 
    • KOCH, Robert. An address on the combatting of tuberculosis in the light of experience that has been gained in the successful combatting of other infectious diseases.. The Lancet. 27 July 1901, s. 187–191. Dostupné online. doi:10.1016/S0140-6736(01)85122-9.  From p. 189: "Considering all these facts, I feel justified in maintaining that human tuberculosis differs from bovine and cannot be transmitted to cattle."

hcsp.fr

  • relatif à l'obligation de vaccination par le BCG des professionnels listés aux articles L [online]. [cit. 2014-02-02]. Dostupné v archivu pořízeném z originálu dne 30 July 2012. 

hemonc.org

  • Sanofi Pasteur Product Monograph – Immucyst [online]. [cit. 2016-02-11]. Dostupné online. 

irishtimes.com

  • O'SULLIVAN, Kevin. Coronavirus: More 'striking' evidence BCG vaccine might protect against covid-19 [online]. [cit. 2020-04-06]. Dostupné online. 

jamanetwork.com

ligazakon.ua

search.ligazakon.ua

mhlw.go.jp

  • 結核とBCGワクチンに関するQ&A｜厚生労働省 [online]. [cit. 2017-07-10]. Dostupné v archivu pořízeném z originálu dne 16 April 2017. (japonsky) 

moh.gov.gr

  • Διακοπή της εφαρμογής καθολικού αντιφυματικού εμβολιασμού (εμβόλιο BCG) στα παιδιά της Α΄ Δημοτικού 2016 [online]. Dostupné online. 

nature.com

nhs.uk

  • BCG tuberculosis (TB) vaccine overview [online]. [cit. 2016-03-27]. Dostupné v archivu pořízeném z originálu dne 1 April 2016. 

nih.gov

ncbi.nlm.nih.gov

  • BCG vaccines: WHO position paper – February 2018. Weekly Epidemiological Record. February 2018, s. 73–96. PMID 29474026. 
  • HAWGOOD, Barbara J. Albert Calmette (1863-1933) and Camille Guérin (1872-1961): the C and G of BCG vaccine. Journal of Medical Biography. August 2007, s. 139–146. Dostupné online. ISSN 0967-7720. doi:10.1258/j.jmb.2007.06-15. PMID 17641786. S2CID 41880560. 
  • LUCA, Simona; MIHAESCU, Traian. History of BCG Vaccine. Mædica. March 2013, s. 53–58. ISSN 1841-9038. PMID 24023600. 
  • Fuge O, Vasdev N, Allchorne P, Green JS. Immunotherapy for bladder cancer. Research and Reports in Urology. May 2015, s. 65–79. doi:10.2147/RRU.S63447. PMID 26000263. 
  • Houghton BB, Chalasani V, Hayne D, Grimison P, Brown CS, Patel MI, Davis ID, Stockler MR. Intravesical chemotherapy plus bacille Calmette–Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis. BJU International. May 2013, s. 977–83. doi:10.1111/j.1464-410X.2012.11390.x. PMID 23253618. S2CID 24961108. 
  • Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, Snell L, Mangtani P, Adetifa I, Lalvani A, Abubakar I. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. August 2014, s. g4643. doi:10.1136/bmj.g4643. PMID 25097193. 
  • Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. March 1994, s. 698–702. doi:10.1001/jama.1994.03510330076038. PMID 8309034. 
  • Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. November 1995, s. 1339–45. doi:10.1016/S0140-6736(95)92348-9. PMID 7475776. S2CID 44737409. 
  • Venkataswamy MM, Goldberg MF, Baena A, Chan J, Jacobs WR, Porcelli SA. In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG. Vaccine. February 2012, s. 1038–49. doi:10.1016/j.vaccine.2011.12.044. PMID 22189700. 
  • Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA. May 2004, s. 2086–91. doi:10.1001/jama.291.17.2086. PMID 15126436. 
  • Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. International Journal of Epidemiology. December 1993, s. 1154–8. doi:10.1093/ije/22.6.1154. PMID 8144299. 
  • Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, Valenti P, Dos Santos S, Duthoy S, Lacroix C, Garcia-Pelayo C, Inwald JK, Golby P, Garcia JN, Hewinson RG, Behr MA, Quail MA, Churcher C, Barrell BG, Parkhill J, Cole ST. Genome plasticity of BCG and impact on vaccine efficacy. Proceedings of the National Academy of Sciences of the United States of America. March 2007, s. 5596–601. doi:10.1073/pnas.0700869104. PMID 17372194. Bibcode 2007PNAS..104.5596B. 
  • Packe GE, Innes JA. Protective effect of BCG vaccination in infant Asians: a case-control study. Archives of Disease in Childhood. March 1988, s. 277–81. doi:10.1136/adc.63.3.277. PMID 3258499. 
  • Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. April 2002, s. 1393–401. doi:10.1016/S0140-6736(02)08353-8. PMID 11978337. S2CID 24334622. 
  • Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. The American Review of Respiratory Disease. October 1966, s. 553–68. doi:10.1164/arrd.1966.94.4.553. PMID 5924215. 
  • Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infection and Immunity. February 2002, s. 672–8. doi:10.1128/IAI.70.2.672-678.2002. PMID 11796598. 
  • Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?. Vaccine. March 2005, s. 2115–20. Dostupné v archivu pořízeném z originálu dne 22 September 2017. doi:10.1016/j.vaccine.2005.01.069. PMID 15755581. 
  • Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infection and Immunity. September 2001, s. 5403–11. doi:10.1128/IAI.69.9.5403-5411.2001. PMID 11500410. 
  • Rentsch CA, Birkhäuser FD, Biot C, Gsponer JR, Bisiaux A, Wetterauer C, Lagranderie M, Marchal G, Orgeur M, Bouchier C, Bachmann A, Ingersoll MA, Brosch R, Albert ML, Thalmann GN. Bacillus Calmette–Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy. European Urology. October 2014, s. 677–88. doi:10.1016/j.eururo.2014.02.061. PMID 24674149. 
  • Brandau S, Suttmann H. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomedicine & Pharmacotherapy. July 2007, s. 299–305. doi:10.1016/j.biopha.2007.05.004. PMID 17604943. 
  • Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA, Sullivan J, Sarosdy MF. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette–Guérin for transitional-cell carcinoma of the bladder. The New England Journal of Medicine. October 1991, s. 1205–9. doi:10.1056/NEJM199110243251703. PMID 1922207. 
  • Mosolits S, Nilsson B, Mellstedt H. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Review of Vaccines. June 2005, s. 329–50. doi:10.1586/14760584.4.3.329. PMID 16026248. S2CID 35749038. 
  • Cuello-García CA, Pérez-Gaxiola G, Jiménez Gutiérrez C. Treating BCG-induced disease in children. The Cochrane Database of Systematic Reviews. January 2013, s. CD008300. doi:10.1002/14651858.CD008300.pub2. PMID 23440826. 
  • Govindarajan KK, Chai FY. BCG Adenitis-Need for Increased Awareness. The Malaysian Journal of Medical Sciences. April 2011, s. 66–9. PMID 22135589.  Malaysian Journal of Medical Sciences Archivováno 26. 3. 2012 na Wayback Machine.
  • NUMMI, Antti; JÄRVINEN, Riikka; SAIRANEN, Jukka; HUOTARI, Kaisa. A retrospective study on tolerability and complications of bacillus Calmette–Guérin (BCG) instillations for non-muscle-invasive bladder cancer. Scandinavian Journal of Urology. 4 May 2019, s. 116–122. Dostupné online. ISSN 2168-1805. doi:10.1080/21681805.2019.1609080. PMID 31074322. S2CID 149444603. (anglicky) 
  • LIU, Yuqing; LU, Jian; HUANG, Yi; MA, Lulin. Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette–Guérin for Bladder Cancer. Journal of Oncology. 10 March 2019, s. 1–11. ISSN 1687-8450. doi:10.1155/2019/6230409. PMID 30984262. (anglicky) 
  • CABAS, Paolo; RIZZO, Michele; GIUFFRÈ, Mauro; ANTONELLO, Roberta Maria; TROMBETTA, Carlo; LUZZATI, Roberto; LIGUORI, Giovanni. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review. Urologic Oncology: Seminars and Original Investigations. February 2021, s. 85–92. Dostupné online. doi:10.1016/j.urolonc.2020.11.037. PMID 33308969. S2CID 229179250. (anglicky) 
  • Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR. Recommendations and Reports. April 1996, s. 1–18. Dostupné online. PMID 8602127. 
  • Revised BCG vaccination guidelines for infants at risk for HIV infection. Weekly Epidemiological Record. May 2007, s. 193–6. PMID 17526121. 
  • Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. April 2006, s. 1173–80. doi:10.1016/S0140-6736(06)68507-3. PMID 16616560. S2CID 40371125. 
  • Mak TK, Hesseling AC, Hussey GD, Cotton MF. Making BCG vaccination programmes safer in the HIV era. Lancet. September 2008, s. 786–7. doi:10.1016/S0140-6736(08)61318-5. PMID 18774406. S2CID 6702107. 
  • Rousseau MC, Conus F, Kâ K, El-Zein M, Parent MÉ, Menzies D. Bacillus Calmette–Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974. Vaccine. August 2017, s. 4777–4784. doi:10.1016/j.vaccine.2017.06.064. PMID 28705514. 
  • Rieckmann A, Villumsen M, Sørup S, Haugaard LK, Ravn H, Roth A, Baker JL, Benn CS, Aaby P. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971-2010. International Journal of Epidemiology. April 2017, s. 695–705. doi:10.1093/ije/dyw120. PMID 27380797. S2CID 3792173. 
  • Gabriele F, Katragkou A, Roilides E. BCG vaccination policy in Greece: time for another review?. The International Journal of Tuberculosis and Lung Disease. October 2014, s. 1258. doi:10.5588/ijtld.14.0282. PMID 25216844. 
  • ZWERLING, A.; BEHR, M. A.; VERMA, A.; BREWER, T. F.; MENZIES, D.; PAI, M. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLOS Medicine. 2011, s. e1001012. doi:10.1371/journal.pmed.1001012. PMID 21445325. 
  • Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle. March 1976, s. 17–43. doi:10.1016/0041-3879(76)90015-5. PMID 1085050. 
  • Chen ZR, Wei XH, Zhu ZY. BCG in China. Chinese Medical Journal. June 1982, s. 437–42. PMID 6813052. 
  • SADEGHI-SHANBESTARI, Mahnaz; ANSARIN, Khalil; MALJAEI, Seyed Hudieh; RAFEEY, Mandana; PEZESHKI, Zakaria; KOUSHA, Ahmmad; BARADARAN, Reza. Immunologic aspects of patients with disseminated bacille Calmette–Guerin disease in north-west of Iran. Italian Journal of Pediatrics. 2009, s. 42. doi:10.1186/1824-7288-35-42. PMID 20030825. 
  • Cernuschi T, Malvolti S, Nickels E, Friede M. Bacillus Calmette–Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine. January 2018, s. 498–506. doi:10.1016/j.vaccine.2017.12.010. PMID 29254839. 
  • Ungar J, Muggleton PW, Dudley JA, Griffiths MI. Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability. Br Med J. October 1962, s. 1086–9. doi:10.1136/bmj.2.5312.1086. PMID 13995378. 
  • PALMER, Mitchell V.; WATERS, W. Ray. Bovine tuberculosis and the establishment of an eradication program in the United States: Role of veterinarians. Veterinary Medicine International. May 2011, s. 816345. doi:10.4061/2011/816345. PMID 21647341. S2CID 18020962.  From p. 2: "In 1895, Smith visited Koch in Europe and described his findings."
  • Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, Stensballe L, Diness BR, Lausch KR, Lund N, Biering-Sørensen S, Whittle H, Benn CS. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. The Journal of Infectious Diseases. July 2011, s. 245–52. doi:10.1093/infdis/jir240. PMID 21673035. 
  • Biering-Sørensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, Benn CS. Small randomized trial among low-birth-weight children receiving bacillus Calmette–Guérin vaccination at first health center contact. The Pediatric Infectious Disease Journal. March 2012, s. 306–8. doi:10.1097/inf.0b013e3182458289. PMID 22189537. S2CID 1240058. 
  • Darrah PA, Zeppa JJ, Maiello P, Hackney JA, Wadsworth MH, Hughes TK, Pokkali S, Swanson PA, Grant NL, Rodgers MA, Kamath M, Causgrove CM, Laddy DJ, Bonavia A, Casimiro D, Lin PL, Klein E, White AG, Scanga CA, Shalek AK, Roederer M, Flynn JL, Seder RA. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. January 2020, s. 95–102. doi:10.1038/s41586-019-1817-8. PMID 31894150. Bibcode 2020Natur.577...95D. 
  • Behar SM, Sassetti C. Tuberculosis vaccine finds an improved route. Nature. January 2020, s. 31–32. doi:10.1038/d41586-019-03597-y. PMID 31894152. S2CID 209528484. Bibcode 2020Natur.577...31B. 
  • The trick that could inject new life into an old tuberculosis vaccine. Nature. January 2020, s. 145. Dostupné online. doi:10.1038/d41586-020-00003-w. PMID 31911698. S2CID 210044794. Bibcode 2020Natur.577..145.. 
  • Kühtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, Zheng H, Faustman DL. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. NPJ Vaccines. 2018, s. 23. doi:10.1038/s41541-018-0062-8. PMID 29951281. 
  • Kowalewicz-Kulbat M, Locht C. BCG and protection against inflammatory and auto-immune diseases. Expert Review of Vaccines. July 2017, s. 699–708. doi:10.1080/14760584.2017.1333906. PMID 28532186. S2CID 4723444. 
  • Weng CH, Saal A, Butt WW, Bica N, Fisher JQ, Tao J, Chan PA. Bacillus Calmette–Guérin vaccination and clinical characteristics and outcomes of covid-19 in Rhode Island, United States: a cohort study. Epidemiology and Infection. July 2020, s. e140. doi:10.1017/S0950268820001569. PMID 32641191. 
  • Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (covid-19). Proceedings of the National Academy of Sciences of the United States of America. July 2020, s. 17720–17726. doi:10.1073/pnas.2008410117. PMID 32647056. S2CID 220469598. 
  • KLINGER, Danielle; BLASS, Ido; RAPPOPORT, Nadav; LINIAL, Michal. Significantly Improved covid-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis. Vaccines. 11 July 2020, s. 378. doi:10.3390/vaccines8030378. PMID 32664505. S2CID 220528079. 
  • SZIGETI, Reka; KELLERMAYER, Domos; TRAKIMAS, Giedrius; KELLERMAYER, Richard. BCG epidemiology supports its protection against covid-19? A word of caution. PLOS ONE. 7 October 2020, s. e0240203. doi:10.1371/journal.pone.0240203. PMID 33027297. Bibcode 2020PLoSO..1540203S. 

pubmed.ncbi.nlm.nih.gov

pidst.net

rch.org.au

  • BCG vaccine for TB [online]. Royal Children's Hospital Melbourne [cit. 2020-03-31]. Dostupné online. 

rxmed.com

sciensano.be

  • Prevention [online]. Dostupné online. 

semanticscholar.org

api.semanticscholar.org

ssi.dk

  • BCG Vaccine Danish Strain 1331 – Statens Serum Institut [online]. Ssi.dk, 19 September 2013 [cit. 2014-02-02]. Dostupné v archivu pořízeném z originálu dne 18 February 2014. 

szu.cz

  • Kopie – cem05_14.p65 [online]. [cit. 2020-04-11]. Dostupné online. 

tandfonline.com

theconversation.com

  • KUPZ, Andreas. Tuberculosis kills as many people each year as covid-19. It's time we found a better vaccine [online]. Dostupné online. 

thl.fi

  • THL [online]. THL [cit. 2020-04-16]. Dostupné online. 

toronto.ca

  • Bacille Calmette–Guerin (BCG) Information for Health Professionals [online]. January 2020 [cit. 2020-04-08]. Dostupné online. 

ucl.ac.uk

discovery.ucl.ac.uk

unicef.org

  • Bacillus Calmette–Guérin Vaccine Supply & Demand Outlook. UNICEF Supply Division. December 2015, s. 5. Dostupné v archivu pořízeném z originálu dne 5 February 2016. 

usm.my

mjms.usm.my

vacunas.org

  • Vacunas disponibles | Vacunas / Asociación Española de Vacunología [online]. Dostupné online. 

web.archive.org

  • BCG Vaccine: WHO position paper. Weekly Epidemiological Record. 23 January 2004, s. 25–40. Dostupné v archivu pořízeném z originálu dne 21 September 2015. 
  • Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?. Vaccine. March 2005, s. 2115–20. Dostupné v archivu pořízeném z originálu dne 22 September 2017. doi:10.1016/j.vaccine.2005.01.069. PMID 15755581. 
  • Nick Makwana and Andrew Riordan (2004), "Is medical therapy effective in the treatment of BCG abscesses?", Birmingham Heartlands Hospital BestBets: Is medical therapy effective in the treatment of BCG abscesses? [online]. [cit. 2007-04-01]. Dostupné v archivu pořízeném z originálu dne 16 February 2007. 
  • Govindarajan KK, Chai FY. BCG Adenitis-Need for Increased Awareness. The Malaysian Journal of Medical Sciences. April 2011, s. 66–9. PMID 22135589.  Malaysian Journal of Medical Sciences Archivováno 26. 3. 2012 na Wayback Machine.
  • Ficha metodológica [online]. [cit. 2021-12-09]. Dostupné v archivu pořízeném dne 2 April 2015. 
  • Задължителни и препоръчителни имунизации [online]. [cit. 2021-12-09]. Dostupné v archivu pořízeném dne 2020-04-11. 
  • relatif à l'obligation de vaccination par le BCG des professionnels listés aux articles L [online]. [cit. 2014-02-02]. Dostupné v archivu pořízeném z originálu dne 30 July 2012. 
  • BCG WORLD ATLAS. A Database of Global BCG Vaccination Policies and Practices [online]. [cit. 2020-04-04]. Dostupné v archivu pořízeném z originálu dne 12 June 2009. 
  • Tuberkulosevaksinasjon – veileder for helsepersonell [online]. %3A0 %3A25 %2C5501&MainContent_6287=6493 %3A0 %3A25 %2C6826&Content_6493=6441 %3A68710 %3A%3A0 %3A6446 %3A1 %3A%3A%3A0 %3A0 Dostupné v archivu pořízeném z originálu dne 7 March 2016. (norsky) 
  • Portugal data [online]. venice.cineca.org [cit. 2021-12-09]. Dostupné v archivu pořízeném dne 7 April 2020. 
  • Ukraine Archivováno 23. 7. 2020 na Wayback Machine. search.ligazakon.ua
  • School 'TB jabs' to be scrapped. BBC News Online. 6 July 2005. Dostupné v archivu pořízeném z originálu dne 6 March 2012. 
  • BCG tuberculosis (TB) vaccine overview [online]. [cit. 2016-03-27]. Dostupné v archivu pořízeném z originálu dne 1 April 2016. 
  • 結核とBCGワクチンに関するQ&A｜厚生労働省 [online]. [cit. 2017-07-10]. Dostupné v archivu pořízeném z originálu dne 16 April 2017. (japonsky) 
  • Thai Pediatrics [online]. Dostupné v archivu pořízeném z originálu dne 19 November 2015. 
  • Mahler HT, Mohamed Ali P. Review of mass B.C.G. project in India. Ind J Tuberculosis. 1955, s. 108–16. Dostupné v archivu pořízeném dne 13 February 2007. 
  • Role of BC Vaccination [online]. [cit. 2021-12-09]. Dostupné v archivu pořízeném dne 6 June 2013. 
  • BCG [online]. South African National Department of Health, 2006 [cit. 2021-12-09]. Dostupné v archivu pořízeném dne 11 May 2013. 
  • Pharmaceutical Information – PACIS [online]. RxMed [cit. 2014-02-02]. %28General%20Monographs-%20P%29/PACIS.html Dostupné v archivu pořízeném z %28General%20Monographs-%20P%29/PACIS.html originálu dne 22 February 2014. 
  • BCG Vaccine Danish Strain 1331 – Statens Serum Institut [online]. Ssi.dk, 19 September 2013 [cit. 2014-02-02]. Dostupné v archivu pořízeném z originálu dne 18 February 2014. 
  • Bacillus Calmette–Guérin Vaccine Supply & Demand Outlook. UNICEF Supply Division. December 2015, s. 5. Dostupné v archivu pořízeném z originálu dne 5 February 2016. 
  • April 2012 Inspectional Observations (form 483). U.S. Food and Drug Administration. 12 April 2012. Dostupné v archivu pořízeném z originálu dne 6 February 2016. 
  • PALMER, Eric. Sanofi Canada vax plant again producing ImmuCyst bladder cancer drug. FiercePharma. 31 March 2015. Dostupné v archivu pořízeném z originálu dne 5 February 2016. 
  • Fact Sheets: BCG Vaccine [online]. Centers for Disease Control and Prevention, 28 October 2011 [cit. 2013-07-18]. Dostupné v archivu pořízeném z originálu dne 20 July 2013. 
  • Vaccination of young children against tuberculosis. [s.l.]: The Hague:Health Council of the Netherlands, 2011. Dostupné v archivu pořízeném z originálu dne 19 February 2014. ISBN 978-90-5549-844-4. 

who.int

who.int

  • BCG Vaccine: WHO position paper. Weekly Epidemiological Record. 23 January 2004, s. 25–40. Dostupné v archivu pořízeném z originálu dne 21 September 2015. 
  • FREEZE - DRIED GLUTAMATE BCG VACCINE (JAPAN) FOR INTRADERMAL USE [online]. World Health Organization [cit. 2021-11-18]. Dostupné online. (English) 
  • Situation Report 13 April 2020 – covid-19 [online]. 13 April 2020 [cit. 2020-04-14]. Dostupné online. 

whqlibdoc.who.int

  • Fine PE, Carneiro IA, Milstein JB, Clements CJ. Issues relating to the use of BCG in immunization programmes: a discussion document [online]. Geneva, Switzerland: World Health Organization, 1999. Kapitola Chapter 8: Reasons for variable efficacy. WHO/V&B/99.23. 

worldcat.org